These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 36647403)

  • 1. Emerging Pharmacotherapies in Alcohol-Associated Hepatitis.
    Wakil A; Niazi M; Meybodi MA; Pyrsopoulos NT
    J Clin Exp Hepatol; 2023; 13(1):116-126. PubMed ID: 36647403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Medical Treatment for Alcohol-Associated Liver Disease.
    Ayares G; Idalsoaga F; Díaz LA; Arnold J; Arab JP
    J Clin Exp Hepatol; 2022; 12(5):1333-1348. PubMed ID: 36157148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel treatments for alcoholic hepatitis.
    German MN; Musto J; Lucey MR
    Curr Opin Gastroenterol; 2021 May; 37(3):179-186. PubMed ID: 33769374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-month assessment of Th-cell axis related inflammatory cytokines, IL-17 and IL-22 and their role in alcohol-associated liver disease.
    Sagaram M; Frimodig J; Jayanty D; Hu H; Royer AJ; Bruner R; Kong M; Schwandt ML; Vatsalya V
    Front Immunol; 2023; 14():1202267. PubMed ID: 38162671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial.
    Cho Y; Park YS; Kim HY; Kim W; Lee HJ; Kim DJ
    Trials; 2018 Dec; 19(1):696. PubMed ID: 30577864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy.
    Subramaniyan V; Chakravarthi S; Jegasothy R; Seng WY; Fuloria NK; Fuloria S; Hazarika I; Das A
    Toxicol Rep; 2021; 8():376-385. PubMed ID: 33680863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of Alcohol-Associated Liver Disease.
    Osna NA; Rasineni K; Ganesan M; Donohue TM; Kharbanda KK
    J Clin Exp Hepatol; 2022; 12(6):1492-1513. PubMed ID: 36340300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut dysbiosis as a driver in alcohol-induced liver injury.
    Fairfield B; Schnabl B
    JHEP Rep; 2021 Apr; 3(2):100220. PubMed ID: 33598648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Granulocyte Colony-Stimulating Factor and N-Acetylcysteine Therapies in Patients With Severe Alcoholic Hepatitis.
    Singh V; Keisham A; Bhalla A; Sharma N; Agarwal R; Sharma R; Singh A
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1650-1656.e2. PubMed ID: 29391265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outnumbered: Control Prothrombin Time in Maddrey's Discriminant Function Impacts Steroid Use but Not Mortality in Alcoholic Hepatitis.
    Healey M; Sterling RK
    Biology (Basel); 2022 Dec; 11(12):. PubMed ID: 36552342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factor for alcoholic hepatitis: A systematic review and meta-analysis of randomised controlled trials.
    Marot A; Singal AK; Moreno C; Deltenre P
    JHEP Rep; 2020 Oct; 2(5):100139. PubMed ID: 32775975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Management and Future Treatment of Alcoholic Hepatitis.
    Mitchell MC; Kerr T; Herlong HF
    Gastroenterol Hepatol (N Y); 2020 Apr; 16(4):178-189. PubMed ID: 34035720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiome and Alcohol-associated Liver Disease.
    Philips CA; Schnabl B; Bajaj JS
    J Clin Exp Hepatol; 2022; 12(5):1349-1359. PubMed ID: 36157139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant gut microbiota related to patterns of drinking and alcohol relapse in patients with alcoholic hepatitis undergoing stool transplant or corticosteroid therapy.
    Philips CA; Ahamed R; Abduljaleel JK; Rajesh S; Tharakan A; Augustine P
    Indian J Gastroenterol; 2023 Oct; 42(5):724-730. PubMed ID: 37548864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoding cell death signals in liver inflammation.
    Brenner C; Galluzzi L; Kepp O; Kroemer G
    J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver regeneration as treatment target for severe alcoholic hepatitis.
    Virovic-Jukic L; Ljubas D; Stojsavljevic-Shapeski S; Ljubičić N; Filipec Kanizaj T; Mikolasevic I; Grgurevic I
    World J Gastroenterol; 2022 Aug; 28(32):4557-4573. PubMed ID: 36157937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in Mice.
    Ambade A; Lowe P; Kodys K; Catalano D; Gyongyosi B; Cho Y; Iracheta-Vellve A; Adejumo A; Saha B; Calenda C; Mehta J; Lefebvre E; Vig P; Szabo G
    Hepatology; 2019 Mar; 69(3):1105-1121. PubMed ID: 30179264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
    de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
    Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in alcoholic hepatitis.
    Veryan J; Forrest EH
    Frontline Gastroenterol; 2020 Mar; 11(2):133-139. PubMed ID: 32133112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Course and Risk Factors for Infection in Severe Forms of Alcohol-Associated Liver Disease.
    Otero Sanchez L; Karakike E; Njimi H; Putignano A; Degré D; Hites M; Jacobs F; Moreno C; Trepo E; Gustot T
    Hepatology; 2021 Nov; 74(5):2714-2724. PubMed ID: 34046927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.